NCT04136041 is a NA clinical trial of Smartphone Application in Subthreshold Depression, sponsored by Kibi International University.

Who is sponsoring NCT04136041?

NCT04136041 is sponsored by Kibi International University.

What drugs are being tested in NCT04136041?

Interventions in NCT04136041: Smartphone Application.

What condition does NCT04136041 study?

NCT04136041 studies Subthreshold Depression.

Is NCT04136041 still recruiting?

NCT04136041 is currently completed. Last updated 1 April 2020.

Last reviewed 2020-04-01 · How we verify

NCT04136041

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression

Completed NA Last updated 1 April 2020

What this trial tests

NA trial testing Smartphone Application in Subthreshold Depression in 32 participants. Completed in 5 March 2020.

Timeline

29 October 2019

Primary endpoint
5 March 2020

5 March 2020

Quick facts

Lead sponsor	Kibi International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	32
Start date	29 October 2019
Primary completion	5 March 2020
Estimated completion	5 March 2020
Sites	1 location across Japan

Drugs / interventions tested

Smartphone Application

Conditions studied

Subthreshold Depression — all drugs for Subthreshold Depression →

Sponsor

Kibi International University

Who can join

18 and older, any sex, with Subthreshold Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators plan to conduct a randomized controlled trial to examine whether a Smartphone-based Intervention improves subthreshold depression symptoms compared to no intervention. The purpose of this pilot randomized controlled trial is to investigate the feasibility of the final randomized controlled trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Study protocol for a pilot randomized controlled trial on a smartphone application-based intervention for subthreshold depression: Study protocol clinical trial (SPIRIT Compliant).
Kato Y, Kageyama K, Mesaki T, Uchida H, et al · · 2020 · cited 4× · PMID 31977910 · DOI 10.1097/md.0000000000018934

Verify or expand the search:

Other trials of Smartphone Application

Trials testing the same drug.

NCT07167654 — Smartphone Application to Support Mothers at Risk of Postpartum Depression · NA · active not recruiting
NCT05169151 — Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Mor · withdrawn
NCT04263974 — Effectiveness of an Exercise Program and Education Through a Mobile Application for the Management of Patients With Hand · NA · completed
NCT04192409 — Glycemic Control Using Mobile-based Intervention in Patients With Diabetes Undergoing Coronary Artery Bypass to Promote · NA · completed
NCT03110016 — Smartphone Intervention for Subthreshold Depression · NA · completed

Other recruiting trials for Subthreshold Depression

Currently open trials in the same condition.

NCT07319143 — The Effect of Transcranial Direct Current Stimulation (tDCS) in Improving Emotion Health · NA · recruiting

Other Kibi International University trials

Trials by the same sponsor.

NCT03864484 — iPad Application-based Intervention for Post-stroke Depression · NA · unknown
NCT03546218 — Effect of Positive-word Stimuli on the Limits of Stability During Multi-direction Reach Operation in Standing Position · NA · completed
NCT03110016 — Smartphone Intervention for Subthreshold Depression · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04136041 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kibi International University
Last refreshed: 1 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04136041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing